Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Exploring ‘best practice’ for nucleic acid detection of Neisseria gonorrhoeae

Exploring ‘best practice’ for nucleic acid detection of Neisseria gonorrhoeae Nucleic acid detection tests (NADT) have considerable benefits for the detection of Neisseria gonorrhoeae (GC), including high sensitivity across a range of specimen types and use under widely differing settings and conditions. However, sexual health practitioners and others who use data generated by NADT for GC should be aware of some important limitations of these tests. False-positive results caused by cross reaction with commensal Neisseria species have been observed in many assays, and have lead to unacceptably low positive-predictive values in some patient populations. Further, false-negative results can be caused by GC sequence variation, with some gonococci lacking certain NADT target sequences. This review examines the issues associated with gonococcal NADT and considers best practice for use of these assays based on current knowledge. We emphasise the need for supplementary testing and extensive assay validation, and suggest appropriate strategies for these requirements irrespective of the setting in which they are used. Further, we highlight the need to maintain culture-based testing for certain specimen sites as well as for antimicrobial resistance surveillance. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Sexual Health CSIRO Publishing

Exploring ‘best practice’ for nucleic acid detection of Neisseria gonorrhoeae

Download PDF
7 pages

Loading next page...
 
/lp/csiro-publishing/exploring-best-practice-for-nucleic-acid-detection-of-neisseria-oNnkmPs0x1

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
CSIRO Publishing
Copyright
CSIRO
ISSN
1448-5028
eISSN
1449-8987
DOI
10.1071/SH07050
Publisher site
See Article on Publisher Site

Abstract

Nucleic acid detection tests (NADT) have considerable benefits for the detection of Neisseria gonorrhoeae (GC), including high sensitivity across a range of specimen types and use under widely differing settings and conditions. However, sexual health practitioners and others who use data generated by NADT for GC should be aware of some important limitations of these tests. False-positive results caused by cross reaction with commensal Neisseria species have been observed in many assays, and have lead to unacceptably low positive-predictive values in some patient populations. Further, false-negative results can be caused by GC sequence variation, with some gonococci lacking certain NADT target sequences. This review examines the issues associated with gonococcal NADT and considers best practice for use of these assays based on current knowledge. We emphasise the need for supplementary testing and extensive assay validation, and suggest appropriate strategies for these requirements irrespective of the setting in which they are used. Further, we highlight the need to maintain culture-based testing for certain specimen sites as well as for antimicrobial resistance surveillance.

Journal

Sexual Health – CSIRO Publishing

Published: Feb 22, 2008

References

  • Applications of molecular testing in clinical laboratories for the diagnosis and control of gonorrhea.
    Tapsall J
  • Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network.
    Smith DW
  • Nucleic acid amplification testing for Neisseria gonorrhoeae : an ongoing challenge.
    Whiley DM
  • A self-administered technique for the detection of sexually transmitted diseases in remote communities.
    Tabrizi SN
  • Global transmission of prolyl-iminipeptidase negative Neisseria gonorrhoeae – implications for changes in diagnostic strategies.
    Unemo M
  • Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections – 2002.
    Johnson RE
  • NAATs: is the time right?
    Ison CGC
  • Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR.
    Farrell DJ
  • Genome plasticity in Neisseria gonorrhoeae.
    Gibbs CP
  • Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis.
    Linz B
  • Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae.
    Palmer HM
  • Diagnostic value of molecular confirmation assays for Neisseria gonorrhoeae.
    Peter-Getzlaff S
  • Use of nucleic acid amplification tests in investigating child sexual abuse.
    Hammerschlag MR
  • A real-time PCR assay for the detection of Neisseria gonorrhoeae by LightCycler.
    Whiley DM
  • Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay.
    Tabrizi SN
  • Evaluation of opa -based real-time PCR for detection of Neisseria gonorrhoeae.
    Tabrizi SN
  • Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR.
    Geraats-Peters CW
  • Neisseria species identification assay for the confirmation of Neisseria gonorrhoeae -positive results of the COBAS Amplicor PCR.
    Mangold KA
  • A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene.
    Whiley DM
  • A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR.
    Lum G
  • Multicenter validation of the cppB gene as a PCR target for detection of Neisseria gonorrhoeae.
    Bruisten SM
  • A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests.
    Ripa T
  • Discrepant analysis is an inappropriate and unscientific method.
    Hadgu A
  • Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.
    Gaydos CA
  • Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae.
    Martin DH
  • The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and Neisseria gonorrhoeae : the infected patient standard reduces sensitivity of single site evaluation.
    Moncada J
  • Cryptic-plasmid-free gonococci may contribute to failure of cppB gene-based assays to confirm results of BD ProbeTEC PCR for identification of Neisseria gonorrhoeae.
    Tapsall JW
  • Use of nucleic amplification tests for the detection of Neisseria gonorrhoeae : survey of genitourinary medicine clinics in England.
    Alloba F